Search research articles
Contact Us
Filters
Showing results (1-10 of 37) with videos related to
Page
of 4
Sort By:
Nature Structural Biology
|
June 25, 2002
Picture story. A pathogenic family business
Hwa-Ping Feng
Nature Structural & Molecular Biology
|
August 28, 2004
Finding 'slicer'
Hwa-ping Feng
Nature Structural & Molecular Biology
|
October 6, 2005
Crossing the species barrier
Hwa-ping Feng
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
December 12, 2018
Population pharmacokinetics of tazobactam/ceftolozane in Japanese patients with complicated urinary tract infection and complicated intra-abdominal infection
Makoto Kakara, Kajal Larson, Hwa-Ping Feng, et al.
Clinical Pharmacokinetics
|
March 20, 2015
Clinical pharmacology profile of boceprevir, a hepatitis C virus NS3 protease inhibitor: focus on drug-drug interactions
Sauzanne Khalilieh, Hwa-Ping Feng, Ellen G J Hulskotte, et al.
Journal of Clinical Pharmacology
|
September 19, 2020
Population Pharmacokinetic Analysis for Plasma and Epithelial Lining Fluid Ceftolozane/Tazobactam Concentrations in Patients With Ventilated Nosocomial Pneumonia
Zufei Zhang, Yogesh T Patel, Jill Fiedler-Kelly, et al.
European Journal of Clinical Pharmacology
|
July 5, 2014
Pharmacokinetic and pharmacodynamic interactions between the hepatitis C virus protease inhibitor, boceprevir, and the oral contraceptive ethinyl estradiol/norethindrone
Wen H Lin, Hwa-Ping Feng, Craig R Shadle, et al.
Hepatology (Baltimore, Md.)
|
May 12, 2012
Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers
Ellen Hulskotte, Samir Gupta, Fengjuan Xuan, et al.
Antimicrobial Agents and Chemotherapy
|
October 31, 2018
Use of Translational Pharmacokinetic/Pharmacodynamic Infection Models To Understand the Impact of Neutropenia on the Efficacy of Tedizolid Phosphate
Jianying Xiao, Charles Gill, Lianzhu Liang, et al.
Cancer Chemotherapy and Pharmacology
|
August 8, 2013
Phase 1 pharmacokinetic study of MK-0646 (dalotuzumab), an anti-insulin-like growth factor-1 receptor monoclonal antibody, in combination with cetuximab and irinotecan in Japanese patients with advanced colorectal cancer
Toshihiko Doi, Kei Muro, Takayuki Yoshino, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 37) with videos related to
Sort By:
Page
of 4
Nature Structural Biology
|
June 25, 2002
Picture story. A pathogenic family business
Hwa-Ping Feng
Nature Structural & Molecular Biology
|
August 28, 2004
Finding 'slicer'
Hwa-ping Feng
Nature Structural & Molecular Biology
|
October 6, 2005
Crossing the species barrier
Hwa-ping Feng
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
December 12, 2018
Population pharmacokinetics of tazobactam/ceftolozane in Japanese patients with complicated urinary tract infection and complicated intra-abdominal infection
Makoto Kakara, Kajal Larson, Hwa-Ping Feng, et al.
Clinical Pharmacokinetics
|
March 20, 2015
Clinical pharmacology profile of boceprevir, a hepatitis C virus NS3 protease inhibitor: focus on drug-drug interactions
Sauzanne Khalilieh, Hwa-Ping Feng, Ellen G J Hulskotte, et al.
Journal of Clinical Pharmacology
|
September 19, 2020
Population Pharmacokinetic Analysis for Plasma and Epithelial Lining Fluid Ceftolozane/Tazobactam Concentrations in Patients With Ventilated Nosocomial Pneumonia
Zufei Zhang, Yogesh T Patel, Jill Fiedler-Kelly, et al.
European Journal of Clinical Pharmacology
|
July 5, 2014
Pharmacokinetic and pharmacodynamic interactions between the hepatitis C virus protease inhibitor, boceprevir, and the oral contraceptive ethinyl estradiol/norethindrone
Wen H Lin, Hwa-Ping Feng, Craig R Shadle, et al.
Hepatology (Baltimore, Md.)
|
May 12, 2012
Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers
Ellen Hulskotte, Samir Gupta, Fengjuan Xuan, et al.
Antimicrobial Agents and Chemotherapy
|
October 31, 2018
Use of Translational Pharmacokinetic/Pharmacodynamic Infection Models To Understand the Impact of Neutropenia on the Efficacy of Tedizolid Phosphate
Jianying Xiao, Charles Gill, Lianzhu Liang, et al.
Cancer Chemotherapy and Pharmacology
|
August 8, 2013
Phase 1 pharmacokinetic study of MK-0646 (dalotuzumab), an anti-insulin-like growth factor-1 receptor monoclonal antibody, in combination with cetuximab and irinotecan in Japanese patients with advanced colorectal cancer
Toshihiko Doi, Kei Muro, Takayuki Yoshino, et al.
Page
of 4